These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6317738)

  • 21. Pyloric channel ulcers: management and three-year follow-up.
    Tekant Y; Goh P; Low C; Ngoi SS
    Am Surg; 1995 Mar; 61(3):237-9. PubMed ID: 7887537
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of ranitidine maintenance treatment of duodenal ulcer.
    Boyd EJ; Wilson JA; Wormsley KG
    Scand J Gastroenterol; 1984 May; 19(3):394-400. PubMed ID: 6330871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of ranitidine and cimetidine ulcer maintenance therapy.
    Kurata JH; Koch GG; Nogawa AN
    J Clin Gastroenterol; 1987 Dec; 9(6):644-50. PubMed ID: 3327884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of sucralfate in peptic disease.
    Jensen SL; Funch Jensen P
    Dig Dis; 1992; 10(3):153-61. PubMed ID: 1611711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rioprostil in the acute and long-term treatment of peptic ulcers: a review.
    Dammann HG; Dreyer M; Müller P; Simon B
    Scand J Gastroenterol Suppl; 1989; 164():207-11; discussion 212-3. PubMed ID: 2510269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptic ulcer in cirrhotic patients: a short- and long-term study with antisecretory drugs.
    Di Mario F; Gottardello L; Germanà B; Dotto P; Grassi SA; Vianello F; Battaglia G; Leandro G; Burra P; Salvagnini M
    Ital J Gastroenterol; 1992; 24(3):122-5. PubMed ID: 1348650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of 'cimetidine-resistant' chronic duodenal ulcers with ranitidine or cimetidine: a randomised multicentre study.
    Quatrini M; Basilisco G; Bianchi PA
    Gut; 1984 Oct; 25(10):1113-7. PubMed ID: 6090280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
    Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
    Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer.
    Van Deventer GM; Elashoff JD; Reedy TJ; Schneidman D; Walsh JH
    N Engl J Med; 1989 Apr; 320(17):1113-9. PubMed ID: 2651924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ranitidine in cimetidine-resistant ulcers.
    Seligman M; Schneiweiss F
    Drug Intell Clin Pharm; 1983 Sep; 17(9):629-30. PubMed ID: 6311504
    [No Abstract]   [Full Text] [Related]  

  • 32. A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer.
    Jensen DM; Cheng S; Kovacs TO; Randall G; Jensen ME; Reedy T; Frankl H; Machicado G; Smith J; Silpa M
    N Engl J Med; 1994 Feb; 330(6):382-6. PubMed ID: 8284002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The efficacy of cimetidine in the treatment of "resistant" duodenal ulcers.
    Young MD; Frank WO; Karlstadt RG; O'Connell S; Palmer RH; Rockhold FW; Kogut DG; Loiudice TA; Orchard JL; Stone RC
    Clin Ther; 1989; 11(4):521-8. PubMed ID: 2673518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs for the prevention of peptic ulcer recurrence.
    Piper DW
    Drugs; 1983 Nov; 26(5):439-53. PubMed ID: 6315333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.
    Grant SM; Langtry HD; Brogden RN
    Drugs; 1989 Jun; 37(6):801-70. PubMed ID: 2667937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ranitidine in the treatment of duodenal ulceration.
    Peden NR; Boyd EJ; Saunders JH; Wormsley KG
    Scand J Gastroenterol; 1981 Apr; 16(3):325-9. PubMed ID: 16435471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
    Brunner GH; Lamberts R; Creutzfeldt W
    Digestion; 1990; 47 Suppl 1():64-8; discussion 76. PubMed ID: 2093018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
    Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
    Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of peptic ulcer with i.v. ranitidine. A treatment possibility in special cases. Experiences from general practice].
    Kemmer R; Taenzer HJ
    Fortschr Med; 1984 Feb; 102(8):201-2. PubMed ID: 6086476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers.
    Delchier JC; Isal JP; Eriksson S; Soule JC
    Gut; 1989 Sep; 30(9):1173-8. PubMed ID: 2680793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.